Skip to content

IMMULITE®/IMMULITE® 1000 Systems E2 Estradiol 10702832Recalls & reported problems

Siemens Healthcare Diagnostics Products Ltd · Class 1

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
1

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 00630414947891), received between Feb 24, 2020 and Feb 24, 2020 — classified as 1 malfunction.

The most frequently reported specific device problem is “High Test Results” (1 report).

1 FDA recall record name this device's identifier.

2 other recalls cover devices cleared under the same FDA submission (K932926); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Recalls naming this device

  1. Feb 5, 2020Class IITerminated

    Due to high discordant Estradiol results which.potentially affects all patient populations, A falsely elevated estradiol level could lead a clinician to misinterpret a patient as pre-menopausal when truly post- menopausal. This may lead to delayed initiation of a potentially beneficial drug and/or administration of an unnecessary drug in the treatment for hormone receptor positive advanced or metastatic breast cancer.

    Z-1513-2020 · Root cause: Under Investigation by firm · Recall details · FDA record ↗

Most reported problems

Device problems

  • High Test Results1

Patient problems

  • No Known Impact Or Consequence To Patient1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 24, 2020High Test Results; High Test Results

    THE CUSTOMER OBSERVED IMPRECISION WHILE COMPARING PATIENT RESULTS FROM ESTRADIOL (E2) LOT 501 TO ESTRADIOL E2 LOT 374 ON IMMULITE 1000. THE CUSTOMER DID NOT CONSIDER THE RESULTS FROM E2 LOT 501 TO BE ACCEPTABLE. THE CUSTOMER DID NOT REPORT PATIENT SAMPLE RESULTS TO THE PHYSICIAN(S). THERE ARE NO KNOWN REPORTS OF PATIENT INTERVENTION OR ADVERSE HEALTH CONSEQUENCES DUE TO THE IMPRECISE E2 RESULTS.

    Patient problems: No Known Impact Or Consequence To Patient

    MAUDE report 9746193 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K932926. One submission often covers many models, so check the product and lot details in each record.

  • Z-1243-2016 · Jan 13, 2016 · Terminated
    IMMULITE 2000 EstradiolTest Code E2 Catalog Number: L2KE22, L2KE22 (D), L2KE26, L2KE26 (D) SMN: 10381178, 10702833, 10381177, 10702834 Product Usage: For in vitro diagnostic use t
  • Z-1242-2016 · Jan 13, 2016 · Terminated
    IMMULITE 1000 Estradiol Test Code E2 Catalog Number: LKE21, LKE21(D), LKE25 SMN: 10381132, 10702832, 10381142 Product Usage: For in vitro diagnostic use with the IMMULITE and IMMU

Other RADIOIMMUNOASSAY, ESTRADIOL devices

All RADIOIMMUNOASSAY, ESTRADIOL devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page